Biomarker for Arteriovenous Fistula Dialysis Access Failure
Application
Plasma biomarker for the prediction of arteriovenous fistula (AVF) dialysis access failure during hemodialysis.
Key Benefits
Circulating chymase levels predict AVF failure in chronic hemodialysis patients.
Proprietary antibody while other proprietary antibodies do not work as biomarkers.
The ability to predict AVF failure may help...
Published: 11/6/2023
Contributor(s): Haimanot Wasse, Ahsan Husain, Angel Rivera
|